Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

cutaneous mastocytosis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A 15-year study on pediatric mastocytosis reveals critical insights into its clinicopathological features and prognosis, emphasizing disease evolution. This research contributes to understanding the long-term outcomes and management strategies for affected children.

A recent study published in PubMed reveals that low bone mineral density (BMD) is uncommon in pediatric patients with mastocytosis. This DEXA-based cohort study provides new insights into the skeletal health of children affected by this rare disease.

Not rare diseases news,news about your rare disease.

Earlier

A 15-year study on pediatric mastocytosis reveals critical insights into its clinicopathological features and prognosis, emphasizing disease evolution. This research contributes to understanding the long-term outcomes and management strategies for affected children.

A recent study published in PubMed reveals that low bone mineral density (BMD) is uncommon in pediatric patients with mastocytosis. This DEXA-based cohort study provides new insights into the skeletal health of children affected by this rare disease.

Not rare diseases news,
news about your rare disease.